Why is the pharmaceutical industry investing in targeted therapies? The emergence of "premium pharma".

Recent decades have witnessed a major transformation in biomedical knowledge production, framed as the rise of personalized, precision, or stratified medicine. While social scientists have explored the implications for disease classification, patient…

Preview only. Read the full abstract at the source